The problem was that it was not feasible for LXR to change indications midway, even though Elirex had also shown efficacy in preclinical models of inflammation and neuroprotection, Hastings adds.
Many patients with inflammatory bowel disease (IBD ... They found that activation of a protein called the Liver X receptor (LXR) can promote regeneration and suppress tumor growth in colorectal ...
Many patients with inflammatory bowel disease (IBD ... They found that activation of a protein called the Liver X receptor (LXR) can promote regeneration and suppress tumour growth in colorectal ...
Many patients with inflammatory bowel disease (IBD ... They found that activation of a protein called the Liver X receptor (LXR) can promote regeneration and suppress tumor growth in colorectal ...